179 related articles for article (PubMed ID: 16459633)
21. [Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology].
Reinacher-Schick AC; Bechstein WO
Internist (Berl); 2007 Jan; 48(1):51-8. PubMed ID: 17160665
[TBL] [Abstract][Full Text] [Related]
22. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients.
Komori H; Beppu T; Baba Y; Horino K; Imsung C; Masuda T; Hayashi H; Okabe H; Ootao R; Watanabe M; Takamori H; Iyama K; Baba H
Int J Clin Oncol; 2010 Jun; 15(3):263-70. PubMed ID: 20238233
[TBL] [Abstract][Full Text] [Related]
23. Feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study.
Kataoka K; Kanazawa A; Nakajima A; Yamaguchi A; Arimoto A; Kohno Y
Surg Today; 2013 Oct; 43(10):1154-61. PubMed ID: 23139049
[TBL] [Abstract][Full Text] [Related]
24. Pathological response of colorectal liver metastases treated after induction treatment.
Ben Slama S; Bacha D; Sassi A; Khadhar A; Bayar R; Bouraoui S; Lahmar A
Tunis Med; 2017 Oct; 95(10):854-858. PubMed ID: 29873054
[TBL] [Abstract][Full Text] [Related]
25. Feasibility and short-term outcome of adjuvant FOLFOX after resection of colorectal liver metastases.
Sakamoto Y; Beppu T; Miyamoto Y; Okabe H; Ida S; Imai K; Chikamoto A; Watanabe M; Takamori H; Baba H
J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):307-12. PubMed ID: 22610308
[TBL] [Abstract][Full Text] [Related]
26. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
Wolf PS; Park JO; Bao F; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Kingham TP; Gönen M; Kemeny N; Shia J; D'Angelica MI
J Am Coll Surg; 2013 Jan; 216(1):41-9. PubMed ID: 23041049
[TBL] [Abstract][Full Text] [Related]
27. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.
Takatsuki M; Tokunaga S; Uchida S; Sakoda M; Shirabe K; Beppu T; Emi Y; Oki E; Ueno S; Eguchi S; Akagi Y; Ogata Y; Baba H; Natsugoe S; Maehara Y;
Eur J Surg Oncol; 2016 Feb; 42(2):184-9. PubMed ID: 26683263
[TBL] [Abstract][Full Text] [Related]
29. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
Alberts SR; Horvath WL; Sternfeld WC; Goldberg RM; Mahoney MR; Dakhil SR; Levitt R; Rowland K; Nair S; Sargent DJ; Donohue JH
J Clin Oncol; 2005 Dec; 23(36):9243-9. PubMed ID: 16230673
[TBL] [Abstract][Full Text] [Related]
30. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.
Coskun U; Buyukberber S; Yaman E; Uner A; Er O; Ozkan M; Dikilitas M; Oguz M; Yildiz R; B DY; Kaya AO; Benekli M
Neoplasma; 2008; 55(1):65-70. PubMed ID: 18190244
[TBL] [Abstract][Full Text] [Related]
31. [A case of liver failure associated with liver damage due to mFOLFOX 6 after resection for multiple liver metastases from colorectal cancer].
Ishizaki T; Abe T; Koyanagi Y; Katsumata K; Wada T; Tsuchida A; Aoki T
Gan To Kagaku Ryoho; 2007 Jun; 34(6):945-8. PubMed ID: 17565263
[TBL] [Abstract][Full Text] [Related]
32. Strategy for synchronous and multiple liver metastasis.
Osada S; Imai H; Sasaki Y; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Takahashi T; Yamaguchi K; Yoshida K
Hepatogastroenterology; 2012; 59(113):198-203. PubMed ID: 22251539
[TBL] [Abstract][Full Text] [Related]
33. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
Reddy SK; Tsung A; Marsh JW; Geller DA
J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
[TBL] [Abstract][Full Text] [Related]
34. The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis.
Scartozzi M; Siquini W; Galizia E; Stortoni P; Marmorale C; Berardi R; Fianchini A; Cascinu S
Dig Liver Dis; 2011 Mar; 43(3):194-8. PubMed ID: 20728416
[TBL] [Abstract][Full Text] [Related]
35. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
[TBL] [Abstract][Full Text] [Related]
36. Benefits and risks of neoadjuvant therapy for liver metastases.
Nordlinger B; Benoist S
J Clin Oncol; 2006 Nov; 24(31):4954-5. PubMed ID: 17075112
[No Abstract] [Full Text] [Related]
37. [Combination of neoadjuvant chemotherapy, cryotherapy and surgery in the treatment of unresectable colorectal liver metastases. Long-term results].
Mariani F; Baldo S; Serventi A; Stella M; Malvezzi E; Meeus P; Kaemmerlen P; Negrier S; Sebban H; DeCian F; Rivoire M
Tumori; 2003; 89(4 Suppl):107-8. PubMed ID: 12903563
[No Abstract] [Full Text] [Related]
38. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties.
Biasco G; Derenzini E; Grazi G; Ercolani G; Ravaioli M; Pantaleo MA; Brandi G
Cancer Treat Rev; 2006 May; 32(3):214-28. PubMed ID: 16546323
[TBL] [Abstract][Full Text] [Related]
39. [Induction chemotherapy and surgery of colorectal liver metastases].
Adam R; Vibert E; Pitombo M
Bull Cancer; 2006 Feb; 93 Suppl 1():S45-9. PubMed ID: 16483945
[TBL] [Abstract][Full Text] [Related]
40. [Colorectal cancer liver metastases -- neoadjuvant concepts for preoperative down-sizing].
Golling M; Gog C; Woeste G; Zapletal C; Wullstein C; Bechstein WO
Zentralbl Chir; 2006 Apr; 131(2):140-7. PubMed ID: 16612781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
